2-159955235-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_007366.5(PLA2R1):āc.3265A>Gā(p.Lys1089Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000807 in 1,611,428 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_007366.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLA2R1 | NM_007366.5 | c.3265A>G | p.Lys1089Glu | missense_variant | 23/30 | ENST00000283243.13 | NP_031392.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PLA2R1 | ENST00000283243.13 | c.3265A>G | p.Lys1089Glu | missense_variant | 23/30 | 1 | NM_007366.5 | ENSP00000283243 | P1 | |
PLA2R1 | ENST00000392771.1 | c.3265A>G | p.Lys1089Glu | missense_variant | 23/27 | 1 | ENSP00000376524 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152236Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000161 AC: 4AN: 249000Hom.: 0 AF XY: 0.0000149 AC XY: 2AN XY: 134630
GnomAD4 exome AF: 0.00000685 AC: 10AN: 1459074Hom.: 0 Cov.: 28 AF XY: 0.00000827 AC XY: 6AN XY: 725930
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152354Hom.: 0 Cov.: 32 AF XY: 0.0000268 AC XY: 2AN XY: 74496
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 17, 2023 | The c.3265A>G (p.K1089E) alteration is located in exon 23 (coding exon 23) of the PLA2R1 gene. This alteration results from a A to G substitution at nucleotide position 3265, causing the lysine (K) at amino acid position 1089 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at